IKS Stock Overview

Operates as a technology-enabled healthcare solutions provider. More details

IKS fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	3/6
Financial Health	3/6
Dividends	0/6

Rewards

Earnings have grown 20.5% per year over the past 5 years

Risk Analysis

Shares are highly illiquid

Has a high level of debt

Profit margins (15.1%) are lower than last year (23.7%)

Significant insider selling over the past 3 months

My Notes

Capture your thoughts, links and company narrative

Inventurus Knowledge Solutions Limited Competitors

Global Health

NSEI:MEDANTA

₹274.2b

Narayana Hrudayalaya

NSEI:NH

₹264.0b

Poly Medicure

BSE:531768

₹254.5b

Aster DM Healthcare

NSEI:ASTERDM

₹247.7b

Price History & Performance

Summary of share price highs, lows and changes for Inventurus Knowledge Solutions
Historical stock prices
Current Share Price	₹1,871.95
52 Week High	₹2,189.00
52 Week Low	₹1,820.00
Beta	0
1 Month Change	-0.73%
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-4.53%

Recent updates

Shareholder Returns

	IKS	IN Healthcare Services	IN Market
7D	-2.2%	-0.3%	-0.3%
1Y	n/a	-19.9%	10.6%

Return vs Industry: Insufficient data to determine how IKS performed against the Indian Healthcare Services industry.

Return vs Market: Insufficient data to determine how IKS performed against the Indian Market.

Price Volatility

Is IKS's price volatile compared to industry and market?
IKS volatility
IKS Average Weekly Movement	n/a
Healthcare Services Industry Average Movement	6.4%
Market Average Movement	6.3%
10% most volatile stocks in IN Market	9.1%
10% least volatile stocks in IN Market	4.2%

Stable Share Price: IKS's share price has been volatile over the past 3 months compared to the Indian market.

Volatility Over Time: Insufficient data to determine IKS's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2006	12,862	Sachin Gupta	ikshealth.com

Inventurus Knowledge Solutions Limited operates as a technology-enabled healthcare solutions provider. The company offers a care enablement platform that assists physician enterprises in outpatient and inpatient care activities in the United States, Canada, and Australia. Its platform serves healthcare organizations, including health systems, academic medical centers, multi-specialty medical groups, single-specialty medical groups, ancillary healthcare organizations, and other outpatient healthcare delivery organizations.

Inventurus Knowledge Solutions Limited Fundamentals Summary

How do Inventurus Knowledge Solutions's earnings and revenue compare to its market cap?
IKS fundamental statistics
Market cap	₹321.18b
Earnings (TTM)	₹3.73b
Revenue (TTM)	₹24.70b

86.1x

P/E Ratio

13.0x

P/S Ratio

Is IKS overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
IKS income statement (TTM)
Revenue	₹24.70b
Cost of Revenue	₹14.04b
Gross Profit	₹10.66b
Other Expenses	₹6.94b
Earnings	₹3.73b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

Feb 05, 2025

Earnings per share (EPS)	21.73
Gross Margin	43.18%
Net Profit Margin	15.10%
Debt/Equity Ratio	60.2%

How did IKS perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/19 07:03
End of Day Share Price	2025/01/17 00:00
Earnings	2024/09/30
Annual Earnings	2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Inventurus Knowledge Solutions Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution

Inventurus Knowledge Solutions NSEI:IKS Stock Report